Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDArmata Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.38 | -$0.38 | -$0.38 |
| Q2 2025 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q3 2025 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2025 | 1 | -$0.19 | -$0.19 | -$0.19 |
Armata Pharmaceuticals, Inc. Earnings Date And Information
Armata Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 12th, 2025. The company reported $-0.42 earnings per share for the quarter, missing analysts' consensus estimates of $-0.42 by $0. The company had revenue of 1.16 M for the quarter and had revenue of 5.17 M for the year. Armata Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.5231 diluted earnings per share) and currently has a price-to-earnings ratio of -4.5. Armata Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based on prior year's report dates.
Armata Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | -$0.42 | -$0.74 | -0.32 | $1.38 M | $1.16 M |
| 08/12/2025 | Q2 2025 | -$0.39 | -$0.45 | -0.06 | $1.38 M | $2.17 M |
| 05/14/2025 | Q1 2025 | -$0.38 | -$0.18 | 0.2 | N/A | $491.00 K |
| 03/20/2025 | Q4 2024 | N/A | $0.07 | N/A | N/A | $1.24 M |
| 11/13/2024 | Q3 2024 | -$0.28 | -$0.15 | 0.13 | $900.00 K | $2.97 M |
| 08/13/2024 | Q2 2024 | -$0.52 | -$0.40 | 0.12 | $1.15 M | $0 |
| 05/07/2024 | Q1 2024 | -$0.28 | -$0.69 | -0.41 | N/A | $966.00 K |
| 03/21/2024 | Q4 2023 | -$0.35 | -$0.55 | -0.2 | N/A | $1.53 M |
| 09/29/2023 | Q3 2023 | N/A | -$0.86 | N/A | $950.00 K | $1.23 M |
| 08/14/2023 | Q2 2023 | -$0.35 | -$0.10 | 0.25 | $1.80 M | $980.00 K |
| 05/11/2023 | Q1 2023 | -$0.29 | -$0.40 | -0.11 | $1.75 M | $796.00 K |
| 03/16/2023 | Q4 2022 | -$0.25 | -$0.29 | -0.04 | $1.67 M | $1.05 M |
| 11/09/2022 | Q3 2022 | -$0.27 | -$0.24 | 0.03 | $1.64 M | $1.34 M |
| 08/11/2022 | Q2 2022 | -$0.26 | -$0.26 | 0 | $1.13 M | $1.88 M |
| 05/12/2022 | Q1 2022 | -$0.20 | -$0.30 | -0.1 | $975.00 K | $1.24 M |
| 03/17/2022 | Q4 2021 | -$0.25 | -$0.25 | 0 | $775.00 K | $989.00 K |
| 11/10/2021 | Q3 2021 | -$0.26 | -$0.22 | 0.04 | $1.08 M | $1.25 M |
| 08/12/2021 | Q2 2021 | -$0.25 | -$0.25 | 0 | $410.00 K | $1.17 M |
| 05/13/2021 | Q1 2021 | -$0.28 | -$0.27 | 0.01 | N/A | $1.07 M |
| 03/18/2021 | Q4 2020 | N/A | -$0.40 | N/A | $270.67 K | $504.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Armata Pharmaceuticals, Inc. Earnings: FAQ's
Armata Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 14th, 2025 based offlast year's report dates.
The conference call for Armata Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Armata Pharmaceuticals, Inc.'s latest earnings report can be read online.
Armata Pharmaceuticals, Inc. (:ARMP) has a recorded annual revenue of $5.17 M.
Armata Pharmaceuticals, Inc. (:ARMP) has a recorded net income of $-18,916,000.Armata Pharmaceuticals, Inc. has generated $-0.5231 earnings per share over the last four quarters.
Armata Pharmaceuticals, Inc. (:ARMP) has a price-to-earnings ratio of -4.5 and price/earnings-to-growth ratio is 0.05.